Paola Minetto

13PUBLICATIONS
70CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Haematological tumoursTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 07, 2026
Like a bolt from the blue: the trauma of facing acute leukemia and lymphoma diagnosis and its clinical implications.

Fabio Guolo, Paola Del Sette, Francesca Riccardi

|Feb 11, 2026
Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.

Salvatore Perrone, Andrea Corbingi, Calogero Vetro

|Dec 05, 2025
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Sep 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.

Fabio Guolo, Luana Fianchi, Maria Paola Martelli

|Oct 25, 2024
Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS.

Thomas Cluzeau, Fabio Guolo, Edmond Chiche

|Jul 23, 2021
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.

Fabio Guolo, Carmen Di Grazia, Paola Minetto

Pageof 3

Frequent Collaborators

11 joint publications

Fabio Guolo

4 joint publications

Carola Riva

4 joint publications

Salvatore Perrone

4 joint publications

Calogero Vetro